In total, 63 drugmakers raised their prices. Most drug prices were raised July 1.
The two drugs that saw the highest price jumps were potassium supplement Effer-K, which increased 34.5 percent, and cancer treatment Proleukin, which increased 20 percent.
Outside of the 125 drugs that saw list price increases, the average list price for all prescription drugs dropped by 0.6 percent.
Read more here.
More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.